Navigation Links
SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials
Date:7/29/2010

AMSTERDAM, July 29, 2010 /PRNewswire/ -- SynCo Bio Partners today announced an extension of its successful collaboration with Versartis, Inc. following the recent initiation of a Phase 1 clinical trial in type 2 diabetes mellitus (T2DM) patients with monthly dosing of VRS-859. This news comes less than 12 months since the parties entered into a strategic partnership to manufacture Versartis' lead product VRS-859 (exenatide-XTEN).

Under the extended agreement, SynCo will scale-up a second manufacturing process on behalf of Versartis, this time in preparation for the GMP manufacture of VRS-317, a once monthly form of human growth hormone for the treatment of children and adults with growth hormone deficiency. As with the VRS-859 program, SynCo will also provide fill and finish services for the manufacture, testing and release of formulated Drug Product vials. SynCo completed process development and optimization, scale-up and GMP manufacture of VRS-859 for Phase 1 clinical studies earlier this year.

"Versartis achieved its first major clinical milestone, a Phase 1 trial of VRS-859, in just over one year after Series A demonstrating our ability to efficiently and quickly execute our development plans," said Jeffrey L. Cleland, Ph.D., Versartis' Chief Executive Officer. "The strength and commitment of our collaborators, such as SynCo Bio Partners, is a key factor in this achievement and we look forward to a similarly successful partnership for our second product, VRS-317."

Pierre Warffemius, SynCo Bio Partners Chief Executive Officer stated, "SynCo is extremely proud of its success in supporting Versartis to progress its pipeline. The VRS-859 manufacturing program was completed on time due to the combined expertise and
'/>"/>

SOURCE SynCo Bio Partners B.V.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SynCo Bio Partners Wins Best Contract Manufacturing Organization 2009 ViE Award
2. SynCo Bio Partners Increases its Capacities by Expanding its Quality Team
3. SynCo Bio Partners to Manufacture Versartis Novel Drug for Type 2 Diabetes
4. SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company
5. SynCo Bio Partners Signs New Manufacturing Agreements to Supply the US Market; Securing its Position as a Market Leader in Microbial Biopharmaceutical Contract Production
6. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
7. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
8. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
9. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
10. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
11. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014 Terascala, the industry leader ... Alan Swahn, a former vice president of product management ... vice president of marketing. Terascala’s software when combined with ... create the highest performance and most reliable solutions for ... guide Terascala’s channel expansion and broaden its product portfolio. ...
(Date:7/10/2014)... July 10, 2014 Senior supply chain ... professional associations, addressed the challenges of “Reducing Cost, Lead ... Industries” through strategic sourcing. Describing the partnership of the ... Supply Chain Management Institute ( SCMI) of the ... June 24 at the Kroc Institute of Peace and ...
(Date:7/10/2014)... 10, 2014 Research and Markets ( ... "International Photonic Integrated Circuit (Monolithic Integration, Hybrid ... report to their offering. ... of photonic integration traces its roots in the ... of photonic integration went unexplored and unfulfilled for ...
(Date:7/10/2014)... the journal PNAS (Proceedings of the National Academy ... and sleep deprivation have a significant effect on our ... the best time of day to test for diseases ... medicines effectively. , Researchers from the University of Surrey ... links between sleep deprivation, body clock disruption and metabolism, ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Time of day crucial to accurately test for diseases, new research finds 2
... Genetics, Inc., (Pinksheets: VRAL) and its President, Haig Keledjian, ... with Timothy and Thomas LLC ("T&T") and its principals ... Settlement ends the almost 5-year-old lawsuit between the parties ... the Northern District of Illinois, originally initiated in March ...
... ANNAPOLIS, Md., Jan. 28, 2011 Anyone curious about ... plasma contributes to lifesaving medicines can now learn about ... Plasma Protein Therapeutics Association (PPTA). "Becoming a Plasma Donor," ... a committed plasma donor at one of the 400-plus ...
... This release is available in Spanish and ... observed for eons. From this fibrous diet consisting mainly of ... substances of no nutritional value to most animals, ruminants manage to ... keepers. And now, the cow, or rather the network ...
Cached Biology Technology:Viral Genetics Settles Litigation and Reacquires African Rights for HIV/AIDS Products 2Viral Genetics Settles Litigation and Reacquires African Rights for HIV/AIDS Products 3New Video on Plasma Donation Available 2How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 2How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 3How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 4How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 5
(Date:7/10/2014)... or even improve the state of fisheries resources ... the Mediterranean has deteriorated over the past 20 ... species reported in the Cell Press journal ... for stringent monitoring of Mediterranean fishing activities, better ... in Mediterranean waters. , Their data show that ...
(Date:7/10/2014)... for Interdisciplinary Research (MIIR) and the Marshall University ... they will be partnering with an international biosciences ... the agreement with Shanghai-based HD Biosciences Co. Ltd., ... risks of discovery and development of these new ... property and commercialization rights to products developed through ...
(Date:7/10/2014)... incubator, received a $1.4 million federal grant to develop ... bleeding during brain surgery. , Surgeons can spray the ... solutions in the gel will cohere and control bleeding ... gel can shorten an intracranial surgery by 30- 45 ... patient,s skull to be open and less anesthesia, reducing ...
Breaking Biology News(10 mins):Mediterranean fish stocks show steady decline 2Marshall University to partner with international company in drug development venture 2A start-up at NJIT develops bleeding-control gel for brain surgery 2
... common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. ... a patient is likely to respond. And, unfortunately, picking the ... this month,s issue of the journal PLoS ONE , ... study used a sophisticated model of ovarian cancer genetics to ...
... Mass. A Navy-sponsored project to design a biologically inspired, swimming ... common bending rules for the tips of wings, fins, flukes, ... animal species. The study, led by John H. ... in Woods Hole, where he is a visiting scientist, is ...
... , , , , ... , AUDIO: Falon Tilley and ... Click here for more information. , ... , , , , ...
Cached Biology News:COXEN model picks the best drug for ovarian cancer 2Quest for jellyfish robot leads to discovery of bending rules for animal wing, fin tips 2Healthy Lunchbox Challenge helps influence healthy eating habits in children 2Healthy Lunchbox Challenge helps influence healthy eating habits in children 3Healthy Lunchbox Challenge helps influence healthy eating habits in children 4
Shake 'n' Stack oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual)...
... - Neurosphere is a system designed for ... neurospheres in a serum free environment. The kit ... which has been optimized for neural stem cell ... Genes & Development 10 :3129). Two growth ...
Request Info...
... RQ1 RNase-Free DNase is a ... single-stranded or double-stranded DNA to produce ... for use in applications where maintaining ... RQ1 DNase is qualified for use ...
Biology Products: